Indian drug makers wary as US FDA sharpens focus on quality controlPost published:May 16, 2017Post category:Industry NewsThe US FDA has increased the frequency of its inspections but also intensified scrutiny on drug manufacturing facilities in India Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostFacebook’s Sheryl Sandberg urges family-friendly policies on Mother’s Day Next PostLithium supply may be key to government’s electric vehicles push You Might Also Like mySCADA announces myPanel smart HMI January 28, 2019 FacilityConneX announces 3.5.0 solution for intelligent alerting December 21, 2019 EVT introduces EyeCheck 1x1x Series with motorized lens October 31, 2019